Can human embryonic stem cells contribute to the discovery of safer and more effective drugs?

Current Opinion in Chemical Biology

Volumn 11, Issue 4, 2007, Pages 405-409

  Cezar, Gabriela Gebrin ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; EMBRYONIC STEM CELL; HEART DEVELOPMENT; HIGH THROUGHPUT SCREENING; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG EVALUATION, PRECLINICAL; DRUG TOXICITY; EMBRYONIC STEM CELLS; HUMANS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS;

EID: 34548126498     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2007.05.033     Document Type: Review

References (39)

1. Kola I., and Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat Rev Drug Discov 3 (2004) 711-715
2. Mayne J.T., Ku W.W., and Kennedy S.P. Informed toxicity assessment in drug discovery: systems-based toxicology. Curr Opin Drug Discov Dev 9 (2006) 75-83
3. Preziosi P. Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario?. Nat Rev Drug Discov 3 (2004) 521-526
4. Davila J.C., Cezar G.G., Thiede M., Strom S., Miki T., and Trosko J. Use and application of stem cells in toxicology. Toxicol Sci 79 (2004) 214-223
5. McNeish J. Embryonic stem cells in drug discovery. Nat Rev Drug Discov 3 (2004) 70-80
6. Yan Y., Yang D., Zarnowska E.D., Du Z., Werbel B., Valliere C., Pearce R.A., Thomson J.A., and Zhang S.C. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23 (2005) 781-790
7. Kumar D., Kamp T.J., and LeWinter M.M. Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regeneration. Coron Artery Dis 16 (2005) 111-116
8. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., Moorman M.A., Kroon E., Carpenter M.K., and Baetge E.E. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24 (2006) 1392-1401
9. Piersma A.H. Alternative methods for developmental toxicity testing. Basic Clin Pharmacol Toxicol 98 (2006) 427-431
10. Greaves P., Williams A., and Eve M. First dose of potential new medicines to humans: how animals help. Nat Rev Drug Discov 3 (2004) 226-236
11. Huuskonen H. New models and molecular markers in evaluation of developmental toxicity. Toxicol Appl Pharmacol 207 2 Suppl. (2005) 495-500
12. Spielmann H., Seiler A., Bremer S., Hareng L., Hartung T., Ahr H., Faustman E., Haas U., Moffat G.J., Nau H., et al. The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM/ZEBET workshop (ECVAM workshop 57). Altern Lab Anim 34 (2006) 527-538
13. Pellizzer C., Bremer S., and Hartung T. Developmental toxicity testing from animal towards embryonic stem cells. ALTEX 22 (2005) 47-57
14. Schrattenholz A., and Klemm M. Neuronal cell culture from human embryonic stem cells as in vitro model for neuroprotection. ALTEX 24 (2007) 9-15
15. Schrattenholz A., Wozny W., Klemm M., Schroer K., Stegmann W., and Cahill M.A. Differential and quantitative molecular analysis of ischemia complexity reduction by isotopic labeling of proteins using a neural embryonic stem cell model. J Neurol Sci 15 (2005) 261-267
16. Dutton G. Entering the Promising Field of Metabolomics. Genet Eng News (2007)
17. Chaudhary K.W., Barrezueta N.X., Bauchmann M.B., Milici A.J., Beckius G., Stedman D.B., Hambor J.E., Blake W.L., McNeish J.D., Bahinski A., and Cezar G.G. Embryonic stem cells in predictive cardiotoxicity: laser capture microscopy enables assay development. Toxicol Sci 90 (2006) 149-158
18. Soto-Gutierrez A., Navarro-Alvarez N., Zhao D., Rivas-Carrillo J.D., Lebkowski J., Tanaka N., Fox I.J., and Kobayashi N. Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat Protoc 2 2 (2007) 347-356
19. Hay D.C., Zhao D., Ross A., Mandalam R., Lebkowski J., and Cui W. Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells 9 (2007) 51-62
20. Soderdahl T., Kuppers-Munther B., Heins N., Edsbagge J., Bjorquist P., Cotgreave I., and Jernstrom B. Glutathione transferases in hepatocyte-like cells derived from human embryonic stem cells. Toxicol In Vitro 21 (2007) 929-937 [Epub ahead of print]
21. Sato N., Meijer L., Skaltsounis L., Greengard P., and Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10 (2004) 55-63
22. Gregory C.A., Gunn W.G., Reyes E., Smolarz A.J., Munoz J., Spees J.L., and Prockop D.J. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow. Ann NY Acad Sci 1049 (2005) 97-106
23. Tu X., Joeng K.S., Nakayama K.I., Nakayama K., Rajagopal J., Carroll T.J., McMahon A.P., and Long F. Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell 12 (2007) 113-127
24. Spinsanti P., De Vita T., Di Castro S., Storto M., Formisano P., Nicoletti F., and Melchiorri D. Endogenously activated mGlu5 metabotropic glutamate receptors sustain the increase in c-Myc expression induced by leukaemia inhibitory factor in cultured mouse embryonic stem cells. J Neurochem 99 (2006) 299-307
25. Gasser T. Genetics of Parkinson's disease. Curr Opin Neurol 18 (2005) 363-369
26. Schneider B.L., Seehus C.R., Capowski E.E., Aebischer P., Zhang S.C., and Svendsen C.N. Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation. Hum Mol Genet 16 (2007) 651-666
27. Ding S., Wu T.Y., Brinker A., Peters E.C., Hur W., Gray N.S., and Schultz P.G. Synthetic small molecules that control stem cell fate. Proc Natl Acad Sci USA 100 (2003) 7632-7637
28. Chen S., Do J.T., Zhang Q., Yao S., Yan F., Peters E.C., Scholer H.R., Schultz P.G., and Ding S. Self-renewal of embryonic stem cells by a small molecule. Proc Natl Acad Sci USA 103 (2006) 17266-17271
29. Wu X., Walker J., Zhang J., Ding S., and Schultz P.G. Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway. Chem Biol 11 (2004) 1229-1238
30. Wu X., Ding S., Ding Q., Gray N.S., and Schultz P.G. Small molecules that induce cardiomyogenesis in embryonic stem cells. J Am Chem Soc 126 (2004) 1590-1591
31. Ding S., and Schultz P.G. A role for chemistry in stem cell biology. Nat Biotechnol 22 (2004) 833-840
32. Chen S., Zhang Q., Wu X., Schultz P.G., and Ding S. Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126 (2004) 410-411
33. Anastasia L., Sampaolesi M., Papini N., Oleari D., Lamorte G., Tringali C., Monti E., Galli D., Tettamanti G., Cossu G., and Venerando B. Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. Cell Death Differ 13 (2006) 2042-2051
34. Warashina M., Min K.H., Kuwabara T., Huynh A., Gage F.H., Schultz P.G., and Ding S. A synthetic small molecule that induces neuronal differentiation of adult hippocampal neural progenitor cells. Angew Chem Int Ed Engl 45 (2006) 591-593
35. Urbanek K., Cesselli D., Rota M., Nascimbene A., De Angelis A., Hosoda T., Bearzi C., Boni A., Bolli R., Kajstura J., et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci USA 103 (2006) 9226-9231
36. Trowbridge J.J., Xenocostas A., Moon R.T., and Bhatia M. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat Med 12 (2006) 89-98
37. Abraham R.T. Signalomic signatures enlighten drug profiling. Nat Chem Biol 2 (2006) 295-296
38. MacDonald M.L., and Westwick J.K. Exploiting network biology to improve drug discovery. Methods Mol Biol 356 (2007) 221-232
39. MacDonald M.L., Lamerdin J., Owens S., Keon B.H., Bilter G.K., Shang Z., Huang Z., Yu H., Dias J., Minami T., et al. Identifying off-target effects and hidden phenotypes of drugs in human cells. Nat Chem Biol 2 (2006) 329-337